View Future GrowthSANGBO 過去の業績過去 基準チェック /06SANGBOの収益は年間平均-71.8%の割合で減少していますが、 Chemicals業界の収益は年間 増加しています。収益は年間1.4% 19.7%割合で 減少しています。主要情報-71.76%収益成長率-71.39%EPS成長率Chemicals 業界の成長13.95%収益成長率-19.69%株主資本利益率-30.14%ネット・マージン-25.71%前回の決算情報31 Dec 2025最近の業績更新Reported Earnings • Mar 17Full year 2025 earnings released: ₩229 loss per share (vs ₩191 loss in FY 2024)Full year 2025 results: ₩229 loss per share (further deteriorated from ₩191 loss in FY 2024). Revenue: ₩50.1b (down 6.9% from FY 2024). Net loss: ₩12.9b (loss widened 19% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 87 percentage points per year, which is a significant difference in performance.Reported Earnings • Mar 14Full year 2024 earnings released: ₩191 loss per share (vs ₩8.00 profit in FY 2023)Full year 2024 results: ₩191 loss per share (down from ₩8.00 profit in FY 2023). Revenue: ₩53.8b (down 19% from FY 2023). Net loss: ₩10.8b (down ₩11.3b from profit in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 106 percentage points per year, which is a significant difference in performance.Reported Earnings • Aug 17Second quarter 2024 earnings released: EPS: ₩22.00 (vs ₩31.00 in 2Q 2023)Second quarter 2024 results: EPS: ₩22.00 (down from ₩31.00 in 2Q 2023). Revenue: ₩15.5b (down 10% from 2Q 2023). Net income: ₩1.24b (down 31% from 2Q 2023). Profit margin: 8.0% (down from 10% in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.Reported Earnings • Mar 19Full year 2023 earnings released: EPS: ₩8.00 (vs ₩67.43 in FY 2022)Full year 2023 results: EPS: ₩8.00 (down from ₩67.43 in FY 2022). Revenue: ₩66.2b (down 1.9% from FY 2022). Net income: ₩438.5m (down 89% from FY 2022). Profit margin: 0.7% (down from 5.9% in FY 2022). Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.Reported Earnings • Nov 19Third quarter 2023 earnings released: EPS: ₩44.00 (vs ₩59.03 in 3Q 2022)Third quarter 2023 results: EPS: ₩44.00 (down from ₩59.03 in 3Q 2022). Revenue: ₩17.4b (up 12% from 3Q 2022). Net income: ₩2.53b (down 26% from 3Q 2022). Profit margin: 15% (down from 22% in 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.Reported Earnings • Mar 14Full year 2022 earnings released: EPS: ₩67.43 (vs ₩82.02 in FY 2021)Full year 2022 results: EPS: ₩67.43 (down from ₩82.02 in FY 2021). Revenue: ₩67.4b (down 6.9% from FY 2021). Net income: ₩4.00b (down 1.6% from FY 2021). Profit margin: 5.9% (up from 5.6% in FY 2021). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 106% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth.すべての更新を表示Recent updatesNew Risk • May 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 72% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Market cap is less than US$100m (₩25.5b market cap, or US$16.9m).Reported Earnings • Mar 17Full year 2025 earnings released: ₩229 loss per share (vs ₩191 loss in FY 2024)Full year 2025 results: ₩229 loss per share (further deteriorated from ₩191 loss in FY 2024). Revenue: ₩50.1b (down 6.9% from FY 2024). Net loss: ₩12.9b (loss widened 19% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 87 percentage points per year, which is a significant difference in performance.お知らせ • Feb 20SANGBO Corp., Annual General Meeting, Mar 26, 2026SANGBO Corp., Annual General Meeting, Mar 26, 2026, at 09:01 Tokyo Standard Time. Location: auditorium, 50, daeseomyeong-ro, tongjin-eup, gyeonggi-do, gimpo South Korea分析記事 • Jan 07The Market Lifts SANGBO Corp. (KOSDAQ:027580) Shares 26% But It Can Do MoreSANGBO Corp. ( KOSDAQ:027580 ) shareholders would be excited to see that the share price has had a great month, posting...New Risk • Jan 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 69% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (9.8% average weekly change). Market cap is less than US$100m (₩54.4b market cap, or US$37.6m).分析記事 • Nov 03Is SANGBO (KOSDAQ:027580) Using Too Much Debt?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...分析記事 • Jul 22SANGBO Corp.'s (KOSDAQ:027580) Share Price Could Signal Some RiskThere wouldn't be many who think SANGBO Corp.'s ( KOSDAQ:027580 ) price-to-sales (or "P/S") ratio of 1.1x is worth a...New Risk • May 23New major risk - Revenue and earnings growthEarnings have declined by 29% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 29% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₩60.4b market cap, or US$44.0m).Reported Earnings • Mar 14Full year 2024 earnings released: ₩191 loss per share (vs ₩8.00 profit in FY 2023)Full year 2024 results: ₩191 loss per share (down from ₩8.00 profit in FY 2023). Revenue: ₩53.8b (down 19% from FY 2023). Net loss: ₩10.8b (down ₩11.3b from profit in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 106 percentage points per year, which is a significant difference in performance.お知らせ • Feb 12SANGBO Corp., Annual General Meeting, Mar 26, 2025SANGBO Corp., Annual General Meeting, Mar 26, 2025, at 09:01 Tokyo Standard Time. Location: auditorium, 50, daeseomyeong-ro, tongjin-eup, gyeonggi-do, gimpo South Korea分析記事 • Dec 14SANGBO Corp. (KOSDAQ:027580) Stock Rockets 27% As Investors Are Less Pessimistic Than ExpectedSANGBO Corp. ( KOSDAQ:027580 ) shares have had a really impressive month, gaining 27% after a shaky period beforehand...New Risk • Dec 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.9% average weekly change). Market cap is less than US$100m (₩63.6b market cap, or US$44.4m).New Risk • Dec 07New minor risk - Financial data availabilityLess than 3 years of financial data is available. This is considered a minor risk. If the company has been trading for less than 3 years, then it has not had the opportunity to establish a long-term track record. This makes it difficult for investors to assess the true growth potential, sustainability and resilience of the business under different economic conditions. Currently, the following risks have been identified for the company: Minor Risks Less than 3 years of financial data is available. Market cap is less than US$100m (₩72.5b market cap, or US$51.0m).分析記事 • Nov 12Is SANGBO (KOSDAQ:027580) Using Debt Sensibly?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Reported Earnings • Aug 17Second quarter 2024 earnings released: EPS: ₩22.00 (vs ₩31.00 in 2Q 2023)Second quarter 2024 results: EPS: ₩22.00 (down from ₩31.00 in 2Q 2023). Revenue: ₩15.5b (down 10% from 2Q 2023). Net income: ₩1.24b (down 31% from 2Q 2023). Profit margin: 8.0% (down from 10% in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.Buy Or Sell Opportunity • May 17Now 23% overvaluedOver the last 90 days, the stock has fallen 11% to ₩1,868. The fair value is estimated to be ₩1,524, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 34% over the last 3 years. Earnings per share has declined by 25%.Buy Or Sell Opportunity • Apr 27Now 20% overvaluedThe stock has been flat over the last 90 days, currently trading at ₩1,840. The fair value is estimated to be ₩1,532, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 34% over the last 3 years. Earnings per share has declined by 25%.お知らせ • Apr 09SANGBO Corp. (KOSDAQ:A027580) announces an Equity Buyback for KRW 1,500 million worth of its shares.SANGBO Corp. (KOSDAQ:A027580) announces a share repurchase program. Under the program, the company will repurchase up to KRW 1,500 million worth of its shares pursuant to a contract with KB Securities Co., Ltd. The purpose of the program is to improve shareholder value and to stabilize stock price. The program will expire on October 8, 2024. As of April 7, 2024, the company had 1,992,650 shares in treasury within scope available for dividend and had 2,022 shares in treasury through other repurchase.Reported Earnings • Mar 19Full year 2023 earnings released: EPS: ₩8.00 (vs ₩67.43 in FY 2022)Full year 2023 results: EPS: ₩8.00 (down from ₩67.43 in FY 2022). Revenue: ₩66.2b (down 1.9% from FY 2022). Net income: ₩438.5m (down 89% from FY 2022). Profit margin: 0.7% (down from 5.9% in FY 2022). Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.New Risk • Feb 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.1% average weekly change). Market cap is less than US$100m (₩112.9b market cap, or US$84.7m).Reported Earnings • Nov 19Third quarter 2023 earnings released: EPS: ₩44.00 (vs ₩59.03 in 3Q 2022)Third quarter 2023 results: EPS: ₩44.00 (down from ₩59.03 in 3Q 2022). Revenue: ₩17.4b (up 12% from 3Q 2022). Net income: ₩2.53b (down 26% from 3Q 2022). Profit margin: 15% (down from 22% in 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Aug 23Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩1,640, the stock trades at a trailing P/E ratio of 49.4x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 30% over the past three years.Valuation Update With 7 Day Price Move • Jul 26Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to ₩1,640, the stock trades at a trailing P/E ratio of 49.4x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 59% over the past three years.New Risk • Jun 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.0% net profit margin).Valuation Update With 7 Day Price Move • Jun 22Investor sentiment improves as stock rises 25%After last week's 25% share price gain to ₩1,966, the stock trades at a trailing P/E ratio of 59.3x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 99% over the past three years.Valuation Update With 7 Day Price Move • Mar 30Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩1,614, the stock trades at a trailing P/E ratio of 23.8x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 134% over the past three years.Reported Earnings • Mar 14Full year 2022 earnings released: EPS: ₩67.43 (vs ₩82.02 in FY 2021)Full year 2022 results: EPS: ₩67.43 (down from ₩82.02 in FY 2021). Revenue: ₩67.4b (down 6.9% from FY 2021). Net income: ₩4.00b (down 1.6% from FY 2021). Profit margin: 5.9% (up from 5.6% in FY 2021). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 106% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jun 23Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₩1,420, the stock trades at a trailing P/E ratio of 34.3x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total loss to shareholders of 1.3% over the past three years.Buying Opportunity • Mar 07Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 11%. The fair value is estimated to be ₩2,210, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 34% per annum over the last 3 years. The company has become profitable over the last 3 years.Reported Earnings • Nov 15Third quarter 2021 earnings released: EPS ₩60.00 (vs ₩17.00 in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: ₩33.0b (down 16% from 3Q 2020). Net income: ₩3.01b (up 282% from 3Q 2020). Profit margin: 9.1% (up from 2.0% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 104% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jun 23Investor sentiment improved over the past weekAfter last week's 28% share price gain to ₩2,665, the stock trades at a trailing P/E ratio of 30.8x. Average trailing P/E is 21x in the Chemicals industry in South Korea. Total returns to shareholders of 47% over the past three years.Valuation Update With 7 Day Price Move • Jun 02Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₩1,955, the stock trades at a trailing P/E ratio of 22.7x. Average trailing P/E is 20x in the Chemicals industry in South Korea. Total returns to shareholders of 5.0% over the past three years.Reported Earnings • May 16First quarter 2021 earnings released: EPS ₩18.00 (vs ₩3.00 loss in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: ₩34.0b (up 17% from 1Q 2020). Net income: ₩851.5m (up ₩969.3m from 1Q 2020). Profit margin: 2.5% (up from net loss in 1Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.分析記事 • Apr 14Returns At SANGBO (KOSDAQ:027580) Are On The Way UpThere are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and...分析記事 • Mar 19SANGBO (KOSDAQ:027580) Has A Somewhat Strained Balance SheetThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...お知らせ • Feb 22SANGBO Corp., Annual General Meeting, Mar 24, 2021SANGBO Corp., Annual General Meeting, Mar 24, 2021, at 09:00 Korea Standard Time.Is New 90 Day High Low • Feb 08New 90-day high: ₩1,530The company is up 18% from its price of ₩1,300 on 10 November 2020. The South Korean market is up 25% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 28% over the same period.分析記事 • Dec 09SANGBO (KOSDAQ:027580) Takes On Some Risk With Its Use Of DebtWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Is New 90 Day High Low • Dec 01New 90-day high: ₩1,490The company is up 3.0% from its price of ₩1,445 on 02 September 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period.Reported Earnings • Nov 13Third quarter 2020 earnings released: ₩4.17 loss per shareThe company reported a solid third quarter result with reduced losses and improved revenues and control over expenses. Third quarter 2020 results: Revenue: ₩15.5b (up 12% from 3Q 2019). Net loss: ₩198.9m (loss narrowed 91% from 3Q 2019). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.収支内訳SANGBO の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史KOSDAQ:A027580 収益、費用、利益 ( )KRW Millions日付収益収益G+A経費研究開発費31 Dec 2550,105-12,8829,9484,73130 Sep 2550,686-15,9999,9756,94030 Jun 2552,450-15,71110,2646,89531 Mar 2552,741-12,75010,9806,33231 Dec 2453,827-10,81912,5835,92030 Sep 2458,204-4,16912,8331,76630 Jun 2461,105-59312,6611,71931 Mar 2462,843-2812,1101,84431 Dec 2366,15743810,6872,02130 Sep 2366,620-43210,2202,75630 Jun 2364,81846010,0322,64531 Mar 2365,4901,9569,4822,47531 Dec 2267,4124,0039,4362,47030 Sep 2225,88410,7576,0542,28830 Jun 2243,30610,3385,6712,23831 Mar 2256,8285,2626,4702,26831 Dec 2172,3894,0697,4722,17830 Sep 21131,7361,95110,1922,25130 Jun 21137,893-26910,4812,16831 Mar 21134,9364,1959,0542,39531 Dec 20130,1143,2268,3672,41730 Sep 20177,05783411,1162,55830 Jun 20151,812-2,12810,9592,80631 Mar 20135,818-9,12811,4292,62931 Dec 19118,221-10,36110,4672,69730 Sep 19-8,735-21,1117,9742,59730 Jun 1914,891-32,0728,4342,58831 Mar 1934,617-32,61211,2052,40431 Dec 1852,698-31,35011,4692,46130 Sep 18126,120-17,64910,8842,13330 Jun 18126,644-4,89311,0071,60831 Mar 18127,917-1,8529,0201,32031 Dec 17127,780-5,88010,6711,07030 Sep 17133,426-14,86012,1141,36530 Jun 17136,313-19,30413,6211,64831 Mar 17139,239-20,25115,9642,05931 Dec 16151,682-20,25716,2522,20130 Sep 16166,336-16,35318,0392,16330 Jun 16170,687-10,72320,4951,65731 Mar 16177,325-9,42618,8291,88531 Dec 15178,636-5,22019,0972,14830 Sep 15175,565-5,72020,7141,96030 Jun 15189,906-5,59020,1921,960質の高い収益: A027580は現在利益が出ていません。利益率の向上: A027580は現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: A027580は利益が出ておらず、過去 5 年間で損失は年間71.8%の割合で増加しています。成長の加速: A027580の過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: A027580は利益が出ていないため、過去 1 年間の収益成長をChemicals業界 ( -3.5% ) と比較することは困難です。株主資本利益率高いROE: A027580は現在利益が出ていないため、自己資本利益率 ( -30.14% ) はマイナスです。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/24 13:20終値2026/05/22 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋SANGBO Corp. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Jeong LeeEugene Investment & Securities Co Ltd.
Reported Earnings • Mar 17Full year 2025 earnings released: ₩229 loss per share (vs ₩191 loss in FY 2024)Full year 2025 results: ₩229 loss per share (further deteriorated from ₩191 loss in FY 2024). Revenue: ₩50.1b (down 6.9% from FY 2024). Net loss: ₩12.9b (loss widened 19% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 87 percentage points per year, which is a significant difference in performance.
Reported Earnings • Mar 14Full year 2024 earnings released: ₩191 loss per share (vs ₩8.00 profit in FY 2023)Full year 2024 results: ₩191 loss per share (down from ₩8.00 profit in FY 2023). Revenue: ₩53.8b (down 19% from FY 2023). Net loss: ₩10.8b (down ₩11.3b from profit in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 106 percentage points per year, which is a significant difference in performance.
Reported Earnings • Aug 17Second quarter 2024 earnings released: EPS: ₩22.00 (vs ₩31.00 in 2Q 2023)Second quarter 2024 results: EPS: ₩22.00 (down from ₩31.00 in 2Q 2023). Revenue: ₩15.5b (down 10% from 2Q 2023). Net income: ₩1.24b (down 31% from 2Q 2023). Profit margin: 8.0% (down from 10% in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.
Reported Earnings • Mar 19Full year 2023 earnings released: EPS: ₩8.00 (vs ₩67.43 in FY 2022)Full year 2023 results: EPS: ₩8.00 (down from ₩67.43 in FY 2022). Revenue: ₩66.2b (down 1.9% from FY 2022). Net income: ₩438.5m (down 89% from FY 2022). Profit margin: 0.7% (down from 5.9% in FY 2022). Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.
Reported Earnings • Nov 19Third quarter 2023 earnings released: EPS: ₩44.00 (vs ₩59.03 in 3Q 2022)Third quarter 2023 results: EPS: ₩44.00 (down from ₩59.03 in 3Q 2022). Revenue: ₩17.4b (up 12% from 3Q 2022). Net income: ₩2.53b (down 26% from 3Q 2022). Profit margin: 15% (down from 22% in 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.
Reported Earnings • Mar 14Full year 2022 earnings released: EPS: ₩67.43 (vs ₩82.02 in FY 2021)Full year 2022 results: EPS: ₩67.43 (down from ₩82.02 in FY 2021). Revenue: ₩67.4b (down 6.9% from FY 2021). Net income: ₩4.00b (down 1.6% from FY 2021). Profit margin: 5.9% (up from 5.6% in FY 2021). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 106% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth.
New Risk • May 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 72% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Market cap is less than US$100m (₩25.5b market cap, or US$16.9m).
Reported Earnings • Mar 17Full year 2025 earnings released: ₩229 loss per share (vs ₩191 loss in FY 2024)Full year 2025 results: ₩229 loss per share (further deteriorated from ₩191 loss in FY 2024). Revenue: ₩50.1b (down 6.9% from FY 2024). Net loss: ₩12.9b (loss widened 19% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 87 percentage points per year, which is a significant difference in performance.
お知らせ • Feb 20SANGBO Corp., Annual General Meeting, Mar 26, 2026SANGBO Corp., Annual General Meeting, Mar 26, 2026, at 09:01 Tokyo Standard Time. Location: auditorium, 50, daeseomyeong-ro, tongjin-eup, gyeonggi-do, gimpo South Korea
分析記事 • Jan 07The Market Lifts SANGBO Corp. (KOSDAQ:027580) Shares 26% But It Can Do MoreSANGBO Corp. ( KOSDAQ:027580 ) shareholders would be excited to see that the share price has had a great month, posting...
New Risk • Jan 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 69% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (9.8% average weekly change). Market cap is less than US$100m (₩54.4b market cap, or US$37.6m).
分析記事 • Nov 03Is SANGBO (KOSDAQ:027580) Using Too Much Debt?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
分析記事 • Jul 22SANGBO Corp.'s (KOSDAQ:027580) Share Price Could Signal Some RiskThere wouldn't be many who think SANGBO Corp.'s ( KOSDAQ:027580 ) price-to-sales (or "P/S") ratio of 1.1x is worth a...
New Risk • May 23New major risk - Revenue and earnings growthEarnings have declined by 29% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 29% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₩60.4b market cap, or US$44.0m).
Reported Earnings • Mar 14Full year 2024 earnings released: ₩191 loss per share (vs ₩8.00 profit in FY 2023)Full year 2024 results: ₩191 loss per share (down from ₩8.00 profit in FY 2023). Revenue: ₩53.8b (down 19% from FY 2023). Net loss: ₩10.8b (down ₩11.3b from profit in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 106 percentage points per year, which is a significant difference in performance.
お知らせ • Feb 12SANGBO Corp., Annual General Meeting, Mar 26, 2025SANGBO Corp., Annual General Meeting, Mar 26, 2025, at 09:01 Tokyo Standard Time. Location: auditorium, 50, daeseomyeong-ro, tongjin-eup, gyeonggi-do, gimpo South Korea
分析記事 • Dec 14SANGBO Corp. (KOSDAQ:027580) Stock Rockets 27% As Investors Are Less Pessimistic Than ExpectedSANGBO Corp. ( KOSDAQ:027580 ) shares have had a really impressive month, gaining 27% after a shaky period beforehand...
New Risk • Dec 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.9% average weekly change). Market cap is less than US$100m (₩63.6b market cap, or US$44.4m).
New Risk • Dec 07New minor risk - Financial data availabilityLess than 3 years of financial data is available. This is considered a minor risk. If the company has been trading for less than 3 years, then it has not had the opportunity to establish a long-term track record. This makes it difficult for investors to assess the true growth potential, sustainability and resilience of the business under different economic conditions. Currently, the following risks have been identified for the company: Minor Risks Less than 3 years of financial data is available. Market cap is less than US$100m (₩72.5b market cap, or US$51.0m).
分析記事 • Nov 12Is SANGBO (KOSDAQ:027580) Using Debt Sensibly?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Reported Earnings • Aug 17Second quarter 2024 earnings released: EPS: ₩22.00 (vs ₩31.00 in 2Q 2023)Second quarter 2024 results: EPS: ₩22.00 (down from ₩31.00 in 2Q 2023). Revenue: ₩15.5b (down 10% from 2Q 2023). Net income: ₩1.24b (down 31% from 2Q 2023). Profit margin: 8.0% (down from 10% in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.
Buy Or Sell Opportunity • May 17Now 23% overvaluedOver the last 90 days, the stock has fallen 11% to ₩1,868. The fair value is estimated to be ₩1,524, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 34% over the last 3 years. Earnings per share has declined by 25%.
Buy Or Sell Opportunity • Apr 27Now 20% overvaluedThe stock has been flat over the last 90 days, currently trading at ₩1,840. The fair value is estimated to be ₩1,532, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 34% over the last 3 years. Earnings per share has declined by 25%.
お知らせ • Apr 09SANGBO Corp. (KOSDAQ:A027580) announces an Equity Buyback for KRW 1,500 million worth of its shares.SANGBO Corp. (KOSDAQ:A027580) announces a share repurchase program. Under the program, the company will repurchase up to KRW 1,500 million worth of its shares pursuant to a contract with KB Securities Co., Ltd. The purpose of the program is to improve shareholder value and to stabilize stock price. The program will expire on October 8, 2024. As of April 7, 2024, the company had 1,992,650 shares in treasury within scope available for dividend and had 2,022 shares in treasury through other repurchase.
Reported Earnings • Mar 19Full year 2023 earnings released: EPS: ₩8.00 (vs ₩67.43 in FY 2022)Full year 2023 results: EPS: ₩8.00 (down from ₩67.43 in FY 2022). Revenue: ₩66.2b (down 1.9% from FY 2022). Net income: ₩438.5m (down 89% from FY 2022). Profit margin: 0.7% (down from 5.9% in FY 2022). Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.
New Risk • Feb 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.1% average weekly change). Market cap is less than US$100m (₩112.9b market cap, or US$84.7m).
Reported Earnings • Nov 19Third quarter 2023 earnings released: EPS: ₩44.00 (vs ₩59.03 in 3Q 2022)Third quarter 2023 results: EPS: ₩44.00 (down from ₩59.03 in 3Q 2022). Revenue: ₩17.4b (up 12% from 3Q 2022). Net income: ₩2.53b (down 26% from 3Q 2022). Profit margin: 15% (down from 22% in 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Aug 23Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩1,640, the stock trades at a trailing P/E ratio of 49.4x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 30% over the past three years.
Valuation Update With 7 Day Price Move • Jul 26Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to ₩1,640, the stock trades at a trailing P/E ratio of 49.4x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 59% over the past three years.
New Risk • Jun 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.0% net profit margin).
Valuation Update With 7 Day Price Move • Jun 22Investor sentiment improves as stock rises 25%After last week's 25% share price gain to ₩1,966, the stock trades at a trailing P/E ratio of 59.3x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 99% over the past three years.
Valuation Update With 7 Day Price Move • Mar 30Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩1,614, the stock trades at a trailing P/E ratio of 23.8x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 134% over the past three years.
Reported Earnings • Mar 14Full year 2022 earnings released: EPS: ₩67.43 (vs ₩82.02 in FY 2021)Full year 2022 results: EPS: ₩67.43 (down from ₩82.02 in FY 2021). Revenue: ₩67.4b (down 6.9% from FY 2021). Net income: ₩4.00b (down 1.6% from FY 2021). Profit margin: 5.9% (up from 5.6% in FY 2021). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 106% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jun 23Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₩1,420, the stock trades at a trailing P/E ratio of 34.3x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total loss to shareholders of 1.3% over the past three years.
Buying Opportunity • Mar 07Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 11%. The fair value is estimated to be ₩2,210, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 34% per annum over the last 3 years. The company has become profitable over the last 3 years.
Reported Earnings • Nov 15Third quarter 2021 earnings released: EPS ₩60.00 (vs ₩17.00 in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: ₩33.0b (down 16% from 3Q 2020). Net income: ₩3.01b (up 282% from 3Q 2020). Profit margin: 9.1% (up from 2.0% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 104% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jun 23Investor sentiment improved over the past weekAfter last week's 28% share price gain to ₩2,665, the stock trades at a trailing P/E ratio of 30.8x. Average trailing P/E is 21x in the Chemicals industry in South Korea. Total returns to shareholders of 47% over the past three years.
Valuation Update With 7 Day Price Move • Jun 02Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₩1,955, the stock trades at a trailing P/E ratio of 22.7x. Average trailing P/E is 20x in the Chemicals industry in South Korea. Total returns to shareholders of 5.0% over the past three years.
Reported Earnings • May 16First quarter 2021 earnings released: EPS ₩18.00 (vs ₩3.00 loss in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: ₩34.0b (up 17% from 1Q 2020). Net income: ₩851.5m (up ₩969.3m from 1Q 2020). Profit margin: 2.5% (up from net loss in 1Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.
分析記事 • Apr 14Returns At SANGBO (KOSDAQ:027580) Are On The Way UpThere are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and...
分析記事 • Mar 19SANGBO (KOSDAQ:027580) Has A Somewhat Strained Balance SheetThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
お知らせ • Feb 22SANGBO Corp., Annual General Meeting, Mar 24, 2021SANGBO Corp., Annual General Meeting, Mar 24, 2021, at 09:00 Korea Standard Time.
Is New 90 Day High Low • Feb 08New 90-day high: ₩1,530The company is up 18% from its price of ₩1,300 on 10 November 2020. The South Korean market is up 25% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 28% over the same period.
分析記事 • Dec 09SANGBO (KOSDAQ:027580) Takes On Some Risk With Its Use Of DebtWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Is New 90 Day High Low • Dec 01New 90-day high: ₩1,490The company is up 3.0% from its price of ₩1,445 on 02 September 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period.
Reported Earnings • Nov 13Third quarter 2020 earnings released: ₩4.17 loss per shareThe company reported a solid third quarter result with reduced losses and improved revenues and control over expenses. Third quarter 2020 results: Revenue: ₩15.5b (up 12% from 3Q 2019). Net loss: ₩198.9m (loss narrowed 91% from 3Q 2019). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.